ALEXANDRIA, Va., March 24 -- United States Patent no. 12,582,656, issued on March 24, was assigned to R.G.C.C. Holdings AG (Zug, Switzerland).
"Nucleotide analogues" was invented by Ioannis Papasotiriou (Oberageri, Switzerland).
According to the abstract* released by the U.S. Patent & Trademark Office: "A compound according to the formula I for use in the treatment of coronavirus infection and/or a respiratory disease caused by a coronavirus, wherein R1 is chosen from alkoxy groups such as for example methoxy or ethoxy, hydroxyl group, and phosphate group, wherein R2 is a group chosen from halogen and/or hydrogen, wherein Y is a nucleic base, preferably a purine or pyrimidine."
The patent was filed on March 23, 2021, under Application No...